MassDevice Big 100 Roundtable West 2012 Slideshow page 3
MassDevice Big 100 Roundtable West 2012 Slideshow page 2
Invisalign trailblazes a path direct to the consumer| A conversation with Align Technology CEO Tom Prescott
Crooked-toothed teens may want to consider sliding a picture of Tom Prescott next to that fading "Twilight" poster on the wall.
AngioDynamics names Navilyst exec chief tech officer post-merger | Personnel Moves
Align Technology gains despite missing Q1 earnings expectations
Shares of Align Technology (NSDQ:ALGN)
rose nearly 16% on Wall Street yesterday after the company reported 1st-quarter sales and earnings growth rates that each hovered around 30%.
U.S. ITC to investigate Align’s overseas competitor
The U.S. International Trade Commission agreed to launch an investigation into Align Technology’s (NSDQ:ALGN) patent infringement claims against overseas competitor ClearCorrect Pakistan and a U.S. affiliate, ClearCorrect Operating.
Ex-Spectranetics CEO convicted of lying to the feds | Legal Roundup
Former Spectranetics (NSDQ:SPNC) CEO John Schulte faces up to 5 years in prison and up to $250,000 in fines after a federal jury in Colorado convicted him on a single count of lying to federal investigators about his role in charges that the company illegally imported laser medical devices for a clinical trial.
The jury acquitted Schulte of 11 other charges including conspiracy to defraud the federal government.
GE, Masimo ink OEM deal | Wall Street Beat
AngioDynamics CEO: Navilyst deal hits the reset button | Wall Street Beat
Updated February 1, 2012 at 5:30 p.m.
The $372 million buyout of Navilyst Medical by AngioDynamics (NSDQ:ANGO) is a reset button that will reinforce the combined operation for the future, AngioDynamics CEO Joe DeVivo told MassDevice this afternoon.
McKesson’s Q3 beats The Street, pays $918M for Canadian pharmacy biz | Earnings Roundup
McKesson (NYSE:MCK) shares got a bump in after-hours trading yesterday when it reported strong 3rd-quarter results and announced the $918 million acquisition of a chain of independent pharmacies in Canada.